Why this matters: This opinion clarifies the limits of DGCL §§ 204 and 205 for charitable nonstock corporations and provides a roadmap for practitioners dealing with governance gaps after a founder-director dies. Estate planners structuring private foundations should ensure succession mechanisms are built into governing documents—bylaws should include automatic successor provisions or grant the personal representative authority to appoint directors.
Whether a court may backdate the appointment of a new director for a charitable nonstock corporation to validate charitable distributions made after the sole director's death, when no authorized director existed at the time of the distributions.
The court denied the amended petition, holding that it cannot backdate the directorial appointment. DGCL §§ 204 and 205—which permit ratification or validation of defective corporate acts—presuppose that a board existed when the act occurred. Where no board existed at all, there is no "defective" act to ratify; there was simply no authorized act.
Magistrate Wright distinguished between a defective corporate act (where a board acted but with some procedural or authorization deficiency) and a non-existent corporate act (where no board existed to act). Section 204 allows a board to ratify its own prior defective acts, but it requires a board to adopt the ratifying resolution. Section 205 allows the court to validate defective acts, but the statute contemplates acts taken by corporate actors, not by persons lacking any corporate authority. The Foundation had no directors, no officers, and no members after Mr. Marks' death in May 2022. The $80,000 in charitable distributions made in August 2023 were not defective board actions—they were actions taken by someone with no corporate authority at all. The court noted that the petitioner has a viable path forward: seek a forward-looking appointment as director (which the Attorney General does not oppose), then use § 204 to ratify the distributions retroactively or petition under § 205 for validation.
Estate planners creating private foundations must build directorial succession into the governing documents. Bylaws should provide for automatic successor directors (e.g., the founder's personal representative or a named successor) to avoid governance gaps upon the founder's death. If a gap has already occurred, the fix is a two-step process: (1) petition the court for a forward-looking director appointment, then (2) have the newly appointed director ratify prior acts under § 204. Do not ask the court to backdate the appointment itself. The Attorney General monitors charitable entities and will object to backdating.
Clarifies the boundary between §§ 204/205 defective-act ratification and governance voids in nonstock charitable corporations. Provides a practical two-step roadmap (appointment + ratification) not previously articulated in published Chancery opinions.
Whether stockholders (including a trust) can maintain derivative claims styled as dual-natured against corporate directors for advancing legal fees to a founder found liable for usurping a corporate opportunity, and for an alleged dilution and overcompensation scheme dating from 2010–2015.
Motions to dismiss granted. The claims are derivative (not dual-natured), some are unripe (advancement claims before final resolution of underlying litigation), and the overcompensation claims are time-barred—plaintiffs had inquiry notice since at least July 2014 and filed suit over six years after limitations expired.
V.C. Will applied the Tooley test and found all claims derivative because the alleged harms (fee advancement, judgment payment, dilution) injured the corporation, not individual stockholders directly. The advancement claims were not ripe because the underlying Deane litigation was still in post-judgment proceedings; advancement is an interim right, and indemnification liability cannot be assessed until proceedings conclude. The dilution/overcompensation claims accrued between 2010–2015, with inquiry notice triggered by a 2014 opinion and stockholder notice. The three-year statute of limitations expired well before the 2024 filing.
Trusts serving as stockholder-plaintiffs in derivative suits face the same standing and timeliness hurdles as individual stockholders. Estate fiduciaries managing trust portfolios that include closely-held company stock should monitor corporate litigation involving portfolio companies and act within limitations periods. The opinion reinforces that advancement claims are premature until underlying proceedings conclude. When advising trust beneficiaries in corporate disputes, watch the clock carefully—inquiry notice can start running from publicly available court opinions.
Reinforces existing Tooley and laches/limitations framework applied to trust-plaintiff stockholders.